Such studies seem to suggest that SNORA71A may bind to LBP in a similar manner in CRC, contributing to an increased binding of LBP to its cognate partner protein and dysregulating the NF-κB pathway, causing the cancer’s hallmark characteristics to manifest (Figure 4a). The gene discussed is LBP; the disease is cancer.